Cancer mutation detection in liquid biopsies

Using the latest technologies, there is no longer need for aggressive and invasive sample obtaining methods such as tissue biopsy to detect the cancer mutations. We use a few microliters of blood plasma or other liquids from body to detect and monitor the levels of cancer mutations based on cancer DNA which is released into the body fluids. Using our ultra-sensitive and state of art cell-free DNA detection technology, we can identify newly developed mutations in very primary stages.

Our rapid, quantitative and ultra-accurate tests help the physicians to choose the most relevant and effective treatment protocols according to the actual cancer status of the patient.  Therefore, we can quantify the therapeutic effect of the treatment in less than a few days.

This page is exclusively designed for health care professionals to introduce our products and dear patients must contact their primary health care specialist for any further assistance.